Glycated Albumin

Lucica^® Glycated Albumin-L liquid biomarker

Lucica-Glycated-Albumin-L-glycemic-control-marker-2

Key features

Specific for glycated albumin (GA)
Measures both glycated albumin and total albumin in separate reactions
Standarized to an established reference (JCCRM611)
Widely published method

Glycated Albumin

The Lucica^® method for Glycated Albumin (GA), manufactured by Asahi Kasei Pharma Corporation, is a specific test for GA that is now FDA cleared for sale in the U.S. The Lucica^®test is distributed exclusively by EKF USA (former Stanbio). The Lucica^®test is one of the most widely used and published GA methods worldwide.

What is Glycated Albumin used for?

Lucica^®is intended to be used for the quantitative measurement of glycated albumin in human serum on compatible clinical chemistry analyzers. The measurement of GA is useful for the intermediate term (preceding 2-3 weeks) monitoring of glycemic control in patients with diabetes. GA is for in vitro diagnostic use only.

Please note that Lucica^® Glycated Albumin is only available from EKF Diagnostics in the USA.

Watch the video

Lucica^® Glycated Albumin-L can fill the gap between long-term and short-term glycemic control marker

What are the advantages of Glycated Albumin testing?

Lucica^® Glycated Albumin-L is specific for GA. It does not measure other glycated proteins such as glycated immunoglobulins.
Measures both glycated albumin and total albumin in separate reactions.
Results are expressed as a ratio, thus minimizing differences in protein concentrations between patients.
Is standardized to an established reference (JCCRM611) via JSCC (Japan Society of Clinical Chemistry).
Over the last decade, numerous studies have been published utilizing the Lucica^® methodology.

Downloads

Lucica^® Glycated Albumin-L Product Sheet

Only available in the USA

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.